GT200600490A - Derivados de isoquinolina y benzo[h]isoquinolina su preparación y su utilización en terapéutica - Google Patents

Derivados de isoquinolina y benzo[h]isoquinolina su preparación y su utilización en terapéutica

Info

Publication number
GT200600490A
GT200600490A GT200600490A GT200600490A GT200600490A GT 200600490 A GT200600490 A GT 200600490A GT 200600490 A GT200600490 A GT 200600490A GT 200600490 A GT200600490 A GT 200600490A GT 200600490 A GT200600490 A GT 200600490A
Authority
GT
Guatemala
Prior art keywords
therapeutics
rent
value
isoquinolina
isoquinoline
Prior art date
Application number
GT200600490A
Other languages
English (en)
Inventor
Juan Antonio Diaz Martin
Beatriz Escribano Aranales
Maria Dolores Jimenez Bargueno
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed filed Critical
Publication of GT200600490A publication Critical patent/GT200600490A/es

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D409/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms
    • C07D409/14—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing three or more hetero rings
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/47—Quinolines; Isoquinolines
    • A61K31/472—Non-condensed isoquinolines, e.g. papaverine
    • A61K31/4725—Non-condensed isoquinolines, e.g. papaverine containing further heterocyclic rings
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/06—Antimigraine agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/08—Antiepileptics; Anticonvulsants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
    • A61P25/16—Anti-Parkinson drugs
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/20—Hypnotics; Sedatives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/22—Anxiolytics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/24—Antidepressants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/30—Drugs for disorders of the nervous system for treating abuse or dependence
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/30—Drugs for disorders of the nervous system for treating abuse or dependence
    • A61P25/32—Alcohol-abuse
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/04—Anorexiants; Antiobesity agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
    • A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
    • C07D401/12—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a chain containing hetero atoms as chain links

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Psychiatry (AREA)
  • Diabetes (AREA)
  • Obesity (AREA)
  • Hematology (AREA)
  • Pain & Pain Management (AREA)
  • Addiction (AREA)
  • Child & Adolescent Psychology (AREA)
  • Psychology (AREA)
  • Hospice & Palliative Care (AREA)
  • Emergency Medicine (AREA)
  • Endocrinology (AREA)
  • Anesthesiology (AREA)
  • Epidemiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Other In-Based Heterocyclic Compounds (AREA)

Abstract

LA PRESENTE INVENCIÓN SE REFIERE A COMPUESTOS DE FÓRMULA I, EN LA QUE A REPRESENTA UN CARBOCICLO ISATURADO CON DOBLES ENLACES, L PUEDE TOMAR UN VALOR DE 0 A 4; M PUEDE TOMAR UN VALOR DE 0 A 3; N PUEDE TOMAR UN VALOR DE 0 A 6; -(C)L, -(C)M- Y -(C)N- REPRESENTAN, INDEPENDIENTEMENTE UNO DEL OTRO, UN GRUPO ALQUILIDENO -CX-Z-, OPCIONALMENTE SUSTITUIDO CON 1 A 4 SUSTITUYENTES R1 REPRESENTA UN ÁTOMO DE HIDRÓGENO, UN GRUPO ALQUILO C1-3, UN ALQUIL C1-6-CARBONILO, UN ALCOXIC1-6-CARBONILO; R2 REPRESENTA UN ÁTOMO DE HIDRÓGENO O UN GRUPO ALQUILO C1-6 O CICLOALQUILO C3-6 OPCIIONALMENTE SUSTITUIDOS, Y SUS USOS EN TERAPÉUTICA PARA FABRICAR MEDICAMENTOS PARA TRATAR LA OBESIDAD, DIABÉTES, ENFERMEDADES DEL SISTEMA NERVIOSO. T2006
GT200600490A 2005-11-24 2006-11-20 Derivados de isoquinolina y benzo[h]isoquinolina su preparación y su utilización en terapéutica GT200600490A (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
EP05111248A EP1790646A1 (fr) 2005-11-24 2005-11-24 Derives de Isoquinoline et Benzo[h]Isoquinoline, leur preparation et leur utilisation en thérapeutique en tant qu'antagonistes du recepteur de l'histamine H3.

Publications (1)

Publication Number Publication Date
GT200600490A true GT200600490A (es) 2007-07-06

Family

ID=36295552

Family Applications (1)

Application Number Title Priority Date Filing Date
GT200600490A GT200600490A (es) 2005-11-24 2006-11-20 Derivados de isoquinolina y benzo[h]isoquinolina su preparación y su utilización en terapéutica

Country Status (25)

Country Link
US (1) US7678807B2 (es)
EP (2) EP1790646A1 (es)
JP (1) JP5165578B2 (es)
KR (1) KR101386318B1 (es)
CN (1) CN101312961B (es)
AR (1) AR057615A1 (es)
AT (1) ATE531707T1 (es)
AU (1) AU2006316706B2 (es)
BR (1) BRPI0618971A2 (es)
CA (1) CA2630655C (es)
CY (1) CY1112386T1 (es)
DK (1) DK1960387T3 (es)
DO (1) DOP2006000253A (es)
ES (1) ES2376894T3 (es)
GT (1) GT200600490A (es)
HK (1) HK1126200A1 (es)
IL (1) IL191214A (es)
PE (1) PE20070827A1 (es)
PL (1) PL1960387T3 (es)
PT (1) PT1960387E (es)
RU (1) RU2418794C2 (es)
SI (1) SI1960387T1 (es)
TW (1) TW200738681A (es)
UY (1) UY29971A1 (es)
WO (1) WO2007060027A1 (es)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2870846B1 (fr) 2004-05-25 2006-08-04 Sanofi Synthelabo Derives de tetrahydroisoquinolylsulfonamides, leur preparation et leur utilisation en therapeutique
EP2569304A1 (en) * 2010-05-11 2013-03-20 Sanofi Substituted n-heteroaryl spirolactam bipyrrolidines, preparation and therapeutic use thereof
AR081384A1 (es) * 2010-05-11 2012-08-29 Sanofi Aventis N- fenil espirolactama bipirrolidinas sustituidas, preparacion y uso terapeutico de las mismas
WO2011143161A1 (en) * 2010-05-11 2011-11-17 Sanofi Substituted n-heterocycloalkyl bipyrrolidinylphenyl amide derivatives, preparation and therapeutic use thereof
AR083718A1 (es) * 2010-05-11 2013-03-20 Sanofi Aventis Fenil cicloalquil pirrolidina (piperidina) espirolactamas y amidas sustituidas, preparacion y uso terapeutico de las mismas
EP2647377A1 (en) 2012-04-06 2013-10-09 Sanofi Use of an h3 receptor antagonist for the treatment of alzheimer's disease

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN1305470A (zh) * 1998-04-10 2001-07-25 日本烟草产业株式会社 脒化合物
CA2347095A1 (en) * 1998-10-16 2000-04-27 Takeda Chemical Industries, Ltd. Nitrogen-containing condensed heterocyclic derivatives, their production and agent
JP2004532834A (ja) * 2001-03-23 2004-10-28 イーライ・リリー・アンド・カンパニー ヒスタミンｈ３受容体アンタゴニストである非イミダゾール系アリールアルキルアミン化合物、その製造および治療的使用
NL1020155C2 (nl) * 2002-03-11 2003-09-17 Bernardus Johannes Jos Bekkers Inrichting voor het dragen van een golftas alsmede werkwijze voor het vervaardigen ervan.
GB0206033D0 (en) * 2002-03-14 2002-04-24 Pfizer Ltd Compounds useful in therapy
JP2006500376A (ja) * 2002-08-20 2006-01-05 イーライ・リリー・アンド・カンパニー ヒスタミンｈ３受容体アンタゴニストとしての置換アゼピン、製造および治療上の使用
GB0408083D0 (en) * 2004-04-08 2004-05-12 Glaxo Group Ltd Novel compounds
FR2870846B1 (fr) * 2004-05-25 2006-08-04 Sanofi Synthelabo Derives de tetrahydroisoquinolylsulfonamides, leur preparation et leur utilisation en therapeutique

Also Published As

Publication number Publication date
EP1960387A1 (fr) 2008-08-27
HK1126200A1 (en) 2009-08-28
DK1960387T3 (da) 2012-02-27
EP1790646A1 (fr) 2007-05-30
CA2630655A1 (fr) 2007-05-31
ATE531707T1 (de) 2011-11-15
PT1960387E (pt) 2012-02-09
BRPI0618971A2 (pt) 2011-09-20
CY1112386T1 (el) 2015-12-09
SI1960387T1 (sl) 2012-03-30
PL1960387T3 (pl) 2012-03-30
AU2006316706B2 (en) 2012-05-03
US7678807B2 (en) 2010-03-16
WO2007060027A1 (fr) 2007-05-31
KR101386318B1 (ko) 2014-04-17
IL191214A (en) 2012-07-31
CA2630655C (fr) 2014-08-26
RU2418794C2 (ru) 2011-05-20
CN101312961B (zh) 2012-04-11
JP5165578B2 (ja) 2013-03-21
JP2009517357A (ja) 2009-04-30
DOP2006000253A (es) 2007-07-15
UY29971A1 (es) 2007-06-29
ES2376894T3 (es) 2012-03-20
KR20080076910A (ko) 2008-08-20
RU2008125136A (ru) 2009-12-27
CN101312961A (zh) 2008-11-26
PE20070827A1 (es) 2007-08-17
AU2006316706A1 (en) 2007-05-31
US20080269199A1 (en) 2008-10-30
TW200738681A (en) 2007-10-16
AR057615A1 (es) 2007-12-05
EP1960387B1 (fr) 2011-11-02

Similar Documents

Publication Publication Date Title
ECSP13012708A (es) Compuestos y su uso como inhibidores de bace
GT200600490A (es) Derivados de isoquinolina y benzo[h]isoquinolina su preparación y su utilización en terapéutica
ATE523486T1 (de) Pleuromutilinderivate zur behandlung von durch mikroben vermittelten krankheiten
CO6501182A2 (es) Derivados de 1-heterociclil-1,5-dihidro-pirazolo[3,4-d]pirimidin-4-ona y su uso como moduladores de pde9a
MY148429A (en) Novel 1,4-benzothiepin-1,1-dioxide derivatives which are substituted with benzyl groups, method for producing drugs containing said compounds and use thereof
AR070487A1 (es) Derivados de 3- metil- imidazo -( 1,2-b)- piridazina
UY33556A (es) "6-Cicloalquil-pirazolopirimidinonas para el tratamiento de trastornos del SNC"
GT200500049A (es) Derivados de 1,6-naftiridina y 1,8-naftiridina y su uso para tratar la diabetes y trastornos relacionados
CL2008000212A1 (es) Compuestos derivados de fenotiazina; composicion farmaceutica que comprende a dichos compuestos; y su uso para tratar diabetes, reducir los niveles de glucemia, adiccion a nicotina, adiccion al alcohol, trastornos del sistema nervioso central, entre
ECSP077309A (es) Compuestos amido y sus usos como farmaceuticos
DE502007002772D1 (de) Neue mit cyclohexylresten substituierte1,4-benzothiepin-1,1 -dioxidderivate, verfahren zu deren herstellung, diese verbindungen enthaltende arzneimittel und deren verwendung
DE502006006854D1 (de) Substituierte benzo (d) isoaxol-3-yl-amin-verbindungen als analgetika
EA200900136A1 (ru) Пирролопиримидины для фармацевтических композиций
CO6400139A2 (es) Derivados de ciclopenta[c]pirool-2-carboxilatos, su preparación y su aplicación en terapéutica
MY143249A (en) 4-substituted pyrrolidin-2-ones and their use
ECSP099330A (es) Compuesto de indol
MX2009007436A (es) Derivados espirociclicos de acido tetronico.
UY32312A (es) 4-azetidinil-1-heteroaril-ciclohexanol antagonistas del ccr2
CY1111327T1 (el) Υποκατεστημενα παραγωγα κυκλοεξυλοξεικου οξεος
AR060786A1 (es) Variaciones cristalinas de (2s)-(4e)-n-metil-5-[3-(5-isopropoxipiridin)il]-4-penten-2-amina
MX339644B (es) Sales de xantilio 3,6-disustituidas.
CR8735A (es) Derivados de tetrahidroisoquinolinilsulfonamidas, su preparacion y su utilizacion en terapeutica
CY1109569T1 (el) Υποκατεστημενα παραγωγα κυκλοεξανο-1,4-διαμινης
ECSP109961A (es) Derivados de indol-2-ona disustituidos en 3, su preparación y su aplicación en terapéutica
ATE537143T1 (de) Spiro(5.5)undecan derivate